{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T22:51:46Z","timestamp":1754261506646},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.bone.2013.09.021","type":"journal-article","created":{"date-parts":[[2013,10,5]],"date-time":"2013-10-05T22:16:22Z","timestamp":1381011382000},"page":"26-32","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Manipulation of anabolic and catabolic responses with bone morphogenetic protein and zoledronic acid in a rat spinal fusion model"],"prefix":"10.1016","volume":"58","author":[{"given":"Ryuzo","family":"Kodera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyomi","family":"Yoshiiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2013.09.021_bb0005","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/00007632-200208151-00007","article-title":"Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute","volume":"27","author":"Boden","year":"2002","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.bone.2013.09.021_bb0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00002517-199306060-00001","article-title":"The role of fusion and instrumentation in the treatment of degenerative spondylolisthesis with spinal stenosis","volume":"6","author":"Bridwell","year":"1993","journal-title":"J Spinal Disord"},{"key":"10.1016\/j.bone.2013.09.021_bb0015","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/00007632-199309000-00015","article-title":"The use of primary internal fixation in spondylolisthesis","volume":"18","author":"McGuire","year":"1993","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.bone.2013.09.021_bb0020","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2106\/00004623-199173080-00006","article-title":"Results of spinal arthrodesis with pedicle screw-plate fixation","volume":"73","author":"West","year":"1991","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.bone.2013.09.021_bb0025","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00007632-199306150-00006","article-title":"A prospective, randomized study of lumbar fusion. Preliminary results","volume":"18","author":"Zdeblick","year":"1993","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.bone.2013.09.021_bb0030","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/jbmr.5650101110","article-title":"Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity","volume":"10","author":"Kanatani","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.09.021_bb0035","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1359\/jbmr.060411","article-title":"Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development","volume":"21","author":"Okamoto","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.09.021_bb0040","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1126\/science.3201241","article-title":"Novel regulators of bone formation: molecular clones and activities","volume":"242","author":"Wozney","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.bone.2013.09.021_bb0045","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1097\/00007632-200212010-00005","article-title":"Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies","volume":"27","author":"Boden","year":"2002","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.bone.2013.09.021_bb0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00007632-200202150-00006","article-title":"Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate","volume":"27","author":"Suh","year":"2002","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.bone.2013.09.021_bb0055","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/01.brs.0000216444.01888.21","article-title":"A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment","volume":"31","author":"Kanayama","year":"2006","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.bone.2013.09.021_bb0060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.spinee.2006.06.381","article-title":"Posterolateral lumbar spine fusion with INFUSE bone graft","volume":"7","author":"Glassman","year":"2007","journal-title":"Spine J"},{"key":"10.1016\/j.bone.2013.09.021_bb0065","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1097\/01.brs.0000240715.78657.81","article-title":"Clinical outcomes and fusion success at 2years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2\/compression resistant matrix versus iliac crest bone graft","volume":"31","author":"Dimar","year":"2006","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.bone.2013.09.021_bb0070","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0736-0266(02)00011-6","article-title":"Retention of 125I-labeled recombinant human bone morphogenetic protein-2 by biphasic calcium phosphate or a composite sponge in a rabbit posterolateral spine arthrodesis model","volume":"20","author":"Louis-Ugbo","year":"2002","journal-title":"J Orthop Res"},{"issue":"1","key":"10.1016\/j.bone.2013.09.021_bb0075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2013.09.021_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bone.2010.11.008","article-title":"Biochemical and molecular mechanisms of action of bisphosphonates","volume":"49","author":"Rogers","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.09.021_bb0085","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2013.09.021_bb0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1359\/jbmr.061001","article-title":"Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate","volume":"22","author":"Hosking","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.09.021_bb0095","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bmj.327.7413.469","article-title":"Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer","volume":"327","author":"Ross","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2013.09.021_bb0100","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00586-006-0212-y","article-title":"Effect of zoledronic acid in an L6\u2013L7 rabbit spine fusion model","volume":"16","author":"Bransford","year":"2007","journal-title":"Eur Spine J"},{"key":"10.1016\/j.bone.2013.09.021_bb0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0149-2918(03)90005-1","article-title":"Effect of daily and intermittent use of ibandronate on bone mass and bone turnover in postmenopausal osteoporosis: a review of three phase II studies","volume":"25","author":"Schimmer","year":"2003","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.bone.2013.09.021_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","article-title":"Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday","volume":"126","author":"McClung","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.bone.2013.09.021_bb0115","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bone.2011.07.005","article-title":"Manipulation of the anabolic and catabolic responses with BMP-2 and zoledronic acid in a rat femoral fracture model","volume":"49","author":"Doi","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.09.021_bb0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.spinee.2008.08.009","article-title":"A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats","volume":"9","author":"Miyazaki","year":"2009","journal-title":"Spine J"},{"key":"10.1016\/j.bone.2013.09.021_bb0125","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/S0142-9612(03)00337-5","article-title":"Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein","volume":"24","author":"Yamamoto","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.bone.2013.09.021_bb0130","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1359\/jbmr.070318","article-title":"Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair","volume":"22","author":"Amanat","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.09.021_bb0135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1529-9430(03)00427-3","article-title":"The effect of alendronate sodium on spinal fusion: a rabbit model","volume":"4","author":"Lehman","year":"2004","journal-title":"Spine J"},{"key":"10.1016\/j.bone.2013.09.021_bb0140","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.bone.2008.08.124","article-title":"The effect of anti-resorptive therapies on bone graft healing in an ovariectomized rat spinal arthrodesis model","volume":"43","author":"Takahata","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.09.021_bb0145","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1359\/JBMR.050712","article-title":"Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model","volume":"20","author":"Little","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.09.021_bb0150","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1359\/jbmr.2003.18.7.1300","article-title":"Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis","volume":"18","author":"Little","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.09.021_bb0155","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bone.2008.05.019","article-title":"Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling","volume":"43","author":"McDonald","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.09.021_bb0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10195-010-0083-1","article-title":"The effect of zoledronate during bone healing","volume":"11","author":"Matos","year":"2010","journal-title":"J Orthop Traumatol"},{"key":"10.1016\/j.bone.2013.09.021_bb0165","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s005860050210","article-title":"Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: preliminary results","volume":"8","author":"Laursen","year":"1999","journal-title":"Eur Spine J"},{"key":"10.1016\/j.bone.2013.09.021_bb0170","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/01.bsd.0000211231.83716.4b","article-title":"Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2)","volume":"19","author":"McClellan","year":"2006","journal-title":"J Spinal Disord Tech"},{"key":"10.1016\/j.bone.2013.09.021_bb0175","doi-asserted-by":"crossref","first-page":"E277","DOI":"10.1097\/01.brs.0000216442.12092.01","article-title":"Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2","volume":"31","author":"Pradhan","year":"2006","journal-title":"Spine (Phila Pa 1976)"},{"issue":"S1","key":"10.1016\/j.bone.2013.09.021_bb0180","first-page":"S438","article-title":"Histologyindicates bisphosphonate limits transient resorption without decreasing subsequent bone induction in non human primate core defects treated with BMP-2\/ACS","volume":"16","author":"Sheeherman","year":"2001","journal-title":"J Bone Miner Res"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821300375X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821300375X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T10:55:18Z","timestamp":1539341718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632821300375X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":36,"alternative-id":["S875632821300375X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2013.09.021","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manipulation of anabolic and catabolic responses with bone morphogenetic protein and zoledronic acid in a rat spinal fusion model","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2013.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}